Viewing Study NCT00215956


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-25 @ 9:17 PM
Study NCT ID: NCT00215956
Status: COMPLETED
Last Update Posted: 2013-12-23
First Post: 2005-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module